secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2025-04-08T23:59:59+00:00
Accession:  0001641172-25-003135
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 3.02, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health raises up to $2M via discounted equity; appoints three new directors
--------------------------------------------------------------------------------

- Equity purchase agreement with Triton Funds for up to $2M; first tranche 354,988 shares for $25,000.
- Subsequent purchases priced at 75% of lowest 5-day trading price before closing.
- Proceeds for commercial activities and working capital; subject to Nasdaq 19.99% limitation.
- Appointed new directors: Dr. Jeffrey Cohen, John Fraser, Cynthia Hundorfean (eff. Apr 2-6, 2025).
- Julie Carrillo appointed interim Principal Accounting Officer; Dr. Celeste Fralick departed Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000164117225003135/0001641172-25-003135-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000164117225003135/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-003135

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer